Journal
HPB
Volume 21, Issue 12, Pages 1718-1726Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.hpb.2019.04.017
Keywords
-
Categories
Funding
- Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2017R1D1A1B03033718]
- Scientific Research Fund of the Korean Liver Cancer Study Group
Ask authors/readers for more resources
Background: We identified the predictive factors and prognostic significance of transarterial chemoembolization (TACE) for achieving pathologic complete response (pCR) before curative surgery for hepatocellular carcinoma (HCC) in hepatitis B-endemic areas. Methods: Among 753 HCC patients treated with surgery, 124 patients underwent preoperative TACE before liver resection (LR), and 166 before liver transplantation (LT) between 2005 and 2016. Overall survival (OS) and recurrence-free survival (RFS) were analyzed. Pathologic response (PR) was defined as the mean percentage of necrotic area, and pCR was defined as the absence of viable tumor. Results: A total of 34 (27%) and 38 (23%) patients had pCR before LR and LT, respectively. Alphafetoprotein (AFP) < 100 ng/mL and single tumor were significant preoperative predictors of pCR. OS and RFS were significantly improved in patients with pCR or a PR >= 90%, but not in patients with PR >= 50% after LR and LT. On multivariate analyses, PR >= 90% remained an independent predictor of better OS and RFS in LR and LT groups. Conclusion: Overall, our data clearly demonstrate that pCR predicts favorable prognosis after curative surgery for HCC, and predictors of pCR are AFP <100 ng/mL and single tumor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available